Cleared Traditional

K771590 - THYROID STIMULATING HORMONE

K771590 is an FDA 510(k) clearance for THYROID STIMULATING HORMONE, manufactured by New England Nuclear. The device is a Class 2 Chemistry device with product code JLW cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K771590 · New England Nuclear · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1977
Decision
27d
Days
Class 2
Risk

K771590 is an FDA 510(k) clearance for the THYROID STIMULATING HORMONE. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by New England Nuclear (Mchenry, US). The FDA issued a Cleared decision on September 15, 1977 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all New England Nuclear devices

FDA 510(k) Submission Details - K771590

510(k) Number K771590 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 1977
Decision Date September 15, 1977
Days to Decision 27 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 88d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JLW Device Classification - Class 2, Special Controls

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 202
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K771590.
IN VITRO HUMAN TSH RIA TEST
K772109 · Clinical Assays, Inc. · Dec 1977
SERALUTE TSH (RIA)
K771767 · Miles Laboratories, Inc. · Oct 1977
TSH RIA REAGENT SET
K771234 · G.D. Searle and Co. · Oct 1977
TSH RIA TEST SYSTEM
K771222 · Monobind · Aug 1977
HTSH RIA HUMAN THYROID HORMONE RIA
K771235 · Abbott Laboratories · Aug 1977
TSH RADIOIMMUNOASSAY
K770892 · Kallestad Laboratories, Inc. · Jun 1977